Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-22T18:11:19.163Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of hypocholesterolemic dietary and drug therapy on measures of dysphoric emotions

Published online by Cambridge University Press:  16 April 2020

Y Beigel ,
A Peleg ,
A Assali  and
I Nachshon
Y Beigel
Affiliation:
Lipid Unit, Department of Medicine A, Beilinson Medical Center, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Petah Tiqva49 100
A Peleg
Affiliation:
Department of Criminology, Bar-Ilan University, Ramat GanIsrael
A Assali
Affiliation:
Lipid Unit, Department of Medicine A, Beilinson Medical Center, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Petah Tiqva49 100
I Nachshon
Affiliation:
Department of Criminology, Bar-Ilan University, Ramat GanIsrael
Get access

Summary

The question of whether hypocholesterolemic treatment is associated with increased mortality due to suicide, violence and car accidents is controversial and of great importance. We investigated the effect of hypocholesterolemic dietary and drug therapy on dysphoric emotions. Twenty-five hypocholesterolemic men were started on a 3-month dietary modification plan; those who showed unsatisfactory cholesterol reduction were given, in addition, a hypocholesterolemic drug for up to 1 year. Lipid profile and change in dysphoric emotions were measured. During the whole period, a negative correlation was found between cholesterol level and depression. During the dietary period, a significant improvement in depression and guilt with no change in lipid profile was noted. Drug therapy significantly reduced cholesterol levels, with a trend toward increased depression (after 3 months) and a significant increase in aggression and guilt (after 1 year). We conclude that changes in dysphoric emotions occurring during hypocholesterolemic therapy cannot be completely explained by the changes in cholesterol levels.

Keywords

cholesteroldepressiondysphoric emotions
Type
Original article
Information
European Psychiatry , Volume 13 , Issue 6 , September 1998 , pp. 288 - 294
Copyright
Copyright © Elsevier, Paris 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beck, ATWard, CHMendelson, MMock, JErlbaugh, JAn inventory measuring depression Arch Gen Psychiat 1961; 4: 53–63CrossRefGoogle ScholarPubMed
Brown, SLSalive, MEHarris, TBSimonsick, EMGuralnik, JMKohout, FJLow cholesterol concentration and severe depressive symptoms in elderly people Br Med J 1994; 308: 1328–1332CrossRefGoogle ScholarPubMed
Cowen, PJNeuroendocrine measures of 5-HT receptor subtype function in depression Advances Biosci 1992; 85: 287–296Google Scholar
Criqui, MHCholesterol, primary and secondary prevention and all cause mortality Ann Intern Med 1991; 115: 973–976CrossRefGoogle ScholarPubMed
Drusun, SMBurke, JReveley, MLow serum cholesterol and depression Br Med J 1994; 309: 273–274CrossRefGoogle Scholar
Duits, NBos, FMDepressive symptoms and cholesterol lowering drugs Lancet 1993; 341: 114CrossRefGoogle ScholarPubMed
Engelberg, HLow serum cholesterol and suicide Lancet 1992; 339: 727–729CrossRefGoogle ScholarPubMed
Ernst, ESaradeth, TSeidl, SResch, KLFrischenschlager, OCholesterol and depression Arch Intern Med 1994; 154: 1166CrossRefGoogle ScholarPubMed
Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II) JAMA 1993; 269: 3015–3023CrossRefGoogle Scholar
Fowkes, FGRLeng, GCDannan, PTDeary, IJDiemersma, RAHously, ESerum cholesterol, triglyceride and aggression in the general population Lancet 1992; 340: 995–998CrossRefGoogle ScholarPubMed
Frick, MHElo, OHaapa, KHeinonen, OHeinsalmi, PHelo, PHelsinki heart study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia New Engl J Med 1987; 317: 1237–1245CrossRefGoogle ScholarPubMed
Friedewald, WLeseg, RFredrickson, DEstimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative centrifuge Clin Chem 1972; 18: 499–502CrossRefGoogle Scholar
Glueck, CJTieger, MKunkel, RTracy, TSpeirs, JStreicher, PIllig, EImprovement in symptoms of depression and in an index of life Stressors accompany treatment of severe hypertriglyceridemia Biol Psychiatry 1993; 34: 240–252CrossRefGoogle Scholar
Harrison, RWAshton, CHDo cholesterol lowering agents affect brain activity? A comparison of simvastatin, pravastatin and placebo in healthy volunteers Br J Clin Pharmacol 1994; 37: 231–236CrossRefGoogle ScholarPubMed
Hoeg, JMBrewer, B3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the treatment of hypercholesterolemia JAMA 1987; 258: 3532–3536CrossRefGoogle ScholarPubMed
Holme, IRelation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomized trials: use of meta analysis Br Heart J 1993; 69: S42–S47CrossRefGoogle Scholar
Jampel, RFalls, HFAtypical retinitis pigmentosa, acanthocytosis and heredodegenerative neuromuscular disease Arch Ophthalmol 1959; 59: 818–820CrossRefGoogle Scholar
Lechlettnen, MHoppichler, FKonwalinka, GPatsch, JBraunsteinen, HDepressive symptoms in hypercholesterolemic patients treated with pravastatin (letter) Lancet 1992; 340: 910CrossRefGoogle Scholar
Lubin, B2nd ed.Depression adjective check list: manual San Diego: Educational and Industrial Service; 1967.Google Scholar
Mars, HLewis, LARobertson, LAButkus, AWilliams, GHFamilial hypo-beta lipoproteinemia: a genetic disorder of lipid metabolism with nervous system involvement Am J Med 1969; 46: 886–902CrossRefGoogle ScholarPubMed
Morgan, REPalinkas, VABarrett-Cannor, EWingard, DPlasma cholesterol and depressive symptoms in older men Lancet 1993; 341: 75–79CrossRefGoogle ScholarPubMed
Muldoon, FManuck, SMatthews, KALowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials Br Med J 1990; 30: 309–314CrossRefGoogle Scholar
Pekkanen, JNissinen, APussar, SKarvonen, MJSerum cholesterol and risk of accidental or violent death in a 25-year followup Arch Intern Med 1989; 149: 1589–1591CrossRefGoogle ScholarPubMed
Smith, DGShipley, MJMarmot, MGPatel, CLowering cholesterol concentrations and mortality Br Med J 1990; 301: 552Google Scholar
Strandberg, TEValvanne, JTilvis, RSerum lipid and depression Lancet 1993; 341: 433–434CrossRefGoogle ScholarPubMed
Strandberg, TERaikkonen, KPartinen, MPihl, SVanhanen, HMiettinen, TAAssociation of cholesterol lowering by statins with anger and hostility in hypercholesterolemic men Biol Psychiatry 1994; 35: 575–577CrossRefGoogle Scholar
The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease JAMA 251 1984 351–364CrossRefGoogle Scholar
Virkkunen, MSerum cholesterol in antisocial personality Neuropsychobiology 1979; 5: 27–30CrossRefGoogle ScholarPubMed
Virkkunen, MSerum cholesterol in homicidal offenders: a low cholesterol level is connected with a habitually violent tendency under the influence of alcohol Neuropsychobiology 1983; 10: 65–69CrossRefGoogle ScholarPubMed
Weidner, GConnor, SLHobis, JFConnor, WEImprovements in hostility and depression in relation to dietary change and plasma cholesterol lowering: the family heart study Ann Intern Med 1992; 117: 820–823CrossRefGoogle ScholarPubMed
Zelin, MLThe anger self report J Con Clin Psychol 1972; 39: 340CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.